Overview

  • Product name

    [D-Lys3]-GHRP-6 (DLS), Ghrelin receptor (GHS-R1a) and CCR5 antagonist
  • Description

    Ghrelin receptor (GHS-R1a) and CCR5 antagonist
  • Alternative names

    • DLS
  • Biological description

    Ghrelin receptor (GHS-R1a) (IC50 = 0.9 μM) antagonist. Additionally acts as CCR5 antagonist and blocks HIV-1 propagation. Active in vivo.
  • Purity

    > 98%
  • CAS Number

    136054-22-3
  • Chemical structure

    Chemical Structure

Properties

References

This product has been referenced in:

  • Patel K  et al. The GHS-R blocker D-[Lys3] GHRP-6 serves as CCR5 chemokine receptor antagonist. Int J Med Sci 9:51-8 (2012). Read more (PubMed: 22211090) »
  • Traebert M  et al. Ghrelin acts on leptin-responsive neurones in the rat arcuate nucleus. J Neuroendocrinol 14:580-6 (2002). Read more (PubMed: 12121496) »
  • Schiöth HB  et al. Characterization of the binding of MSH-B, HB-228, GHRP-6 and 153N-6 to the human melanocortin receptor subtypes. Neuropeptides 31:565-71 (1997). Read more (PubMed: 9574823) »
See 1 Publication for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab141148.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
For licensing inquiries, please contact partnerships@abcam.com

Sign up